Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment
Open accessThe DOI matches its Crossref record; 78 of the 82 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is an incurable disease associated with aging that destroys sharp and central vision. Increasing evidence implicates both systemic and local inflammation in the pathogenesis of AMD. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is currently the first-line therapy for choroidal neovascularization in AMD patients. However, a high number of patients do not show satisfactory responses to anti-VEGF treatment after three injections. Predictive treatment response models are one of the most powerful tools for personalized medicine. Therefore, the application of these models is very helpful to predict the optimal treatment for an early application on each patient. We analyzed the transcriptome of peripheral blood mononuclear cells (PBMCs) from AMD patients before treatment to identify biomarkers of response to ranibizumab. A classification model comprised of four mRNAs and one miRNA isolated from PBMCs was able to predict the response to ranibizumab with high accuracy (Area Under the Curve of the Receiver Operating Characteristic curve = 0.968), before treatment. We consider that our classification model, based on mRNA and miRNA from PBMCs allows a robust prediction of patients with insufficient response to anti-VEGF treatment. In addition, it could be used in combination with other methods, such as specific baseline characteristics, to identify patients with poor response to anti-VEGF treatment to establish patient-specific treatment plans at the first visit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Transcriptome analysis of peripheral blood mononuclear cells from 59 patients treated with ranibizumab demonstrated that the ranibizumab response could be predicted before treatment [39].”
From Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians. (2024) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades
Friedländer, M. R., Mackowiak, S. D., Li, N., Chen, W., & Rajewsky, N. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr688 · Cited by 3,207
Data, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,092
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
Vlachos, I. S., Zagganas, K., Paraskevopoulou, M. D., Georgakilas, G., Karagkouni, D., Vergoulis, T., Dalamagas, T., & Hatzigeorgiou, A. G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv403 · Cited by 1,699
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Data mining in bioinformatics using Weka
Frank, E., Hall, M., Trigg, L., Holmes, G., & Witten, I. H. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth261 · Cited by 882
Li, S., Rouphael, N., Duraisingham, S., Romero-Steiner, S., Presnell, S., Davis, C., Schmidt, D. S., Johnson, S. E., Milton, A., Rajam, G., et al. (2014) · Nature Immunology · doi:10.1038/ni.2789 · Cited by 770
Schmidt-Erfurth, U., Chong, V., Loewenstein, A., Larsen, M., Souied, E., Schlingemann, R., Eldem, B., Monés, J., Richard, G., & Bandello, F. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305702 · Cited by 639
Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355 · cited 2×
“Classification of patient response was based on Amoaku and collaborators [31].”
BackgroundThe Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Skalsky, R. L., Corcoran, D. L., Gottwein, E., Frank, C. L., Kang, D., Hafner, M., Nusbaum, J. D., Feederle, R., Delecluse, H.-J., Luftig, M. A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002484 · Cited by 352
Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Curcio, C. A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24882 · Cited by 318
Ying, G.-S., Huang, J., Maguire, M. G., Jaffe, G. J., Grunwald, J. E., Toth, C., Daniel, E., Klein, M., Pieramici, D., Wells, J., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.042 · Cited by 305
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12757 · Cited by 282
Yu, Y., Bhangale, T. R., Fagerness, J., Ripke, S., Thorleifsson, G., Tan, P. L., Souied, E. H., Richardson, A. J., Merriam, J. E., Buitendijk, G. H. S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr270 · Cited by 254 · cited 1×
“Involvement of systemic inflammation in the disease is reflected by the association of single nucleotide polymorphisms (SNPs) in complement components [7–10], chemokine receptors [11,12], VEGF isoforms [13,14] and Toll-like receptor-3 [15].”
BackgroundJaffe, G. J., Ying, G.-S., Toth, C. A., Daniel, E., Grunwald, J. E., Martin, D. F., & Maguire, M. G. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.035 · Cited by 248
TMEM Proteins in Cancer: A Review
Schmit, K., & Michiels, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01345 · Cited by 237
Fritsche, L. G., Lauer, N., Hartmann, A., Stippa, S., Keilhauer, C. N., Oppermann, M., Pandey, M. K., Köhl, J., Zipfel, P. F., Weber, B. H. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq399 · Cited by 203
Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi
Li, Y., Oosting, M., Deelen, P., Ricaño-Ponce, I., Smeekens, S., Jaeger, M., Matzaraki, V., Swertz, M. A., Xavier, R. J., Franke, L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4139 · Cited by 188
Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
Lux, A., Llacer, H., Heussen, F. M. A., & Joussen, A. M. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.113902 · Cited by 168
Hagstrom, S. A., Ying, G.-S., Pauer, G. J. T., Sturgill-Short, G. M., Huang, J., Callanan, D. G., Kim, I. K., Klein, M. L., Maguire, M. G., & Martin, D. F. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.037 · Cited by 142
Khanna, S., Komati, R., Eichenbaum, D. A., Hariprasad, I., Ciulla, T. A., & Hariprasad, S. M. (2019) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000398 · Cited by 124
Indaram, M., Ma, W., Zhao, L., Fariss, R. N., Rodriguez, I. R., & Wong, W. T. (2015) · Scientific Reports · doi:10.1038/srep09144 · Cited by 101 · cited 1×
“For instance, the presence of inflammatory mediators of the complement cascade in drusen, macrophages in the choroid of eyes with AMD [5], or anti-retinal autoantibodies and inflammatory markers detected in the sera of patients with AMD [6].”
BackgroundApproaches for Understanding the Mechanisms of Long Noncoding RNA Regulation of Gene Expression
McDonel, P. E., & Guttman, M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032151 · Cited by 101
Toward an elucidation of the molecular genetics of inherited retinal degenerations
Farrar, G. J., Carrigan, M., Dockery, A., Millington-Ward, S., Palfi, A., Chadderton, N., Humphries, M., Kiang, A. S., Kenna, P. F., & Humphries, P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx185 · Cited by 94
MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
Ménard, C., Rezende, F. A., Miloudi, K., Wilson, A., Tétreault, N., Hardy, P., SanGiovanni, J. P., De Guire, V., & Sapieha, P. (2016) · Oncotarget · doi:10.18632/oncotarget.8280 · Cited by 93
Gallardo, M., Munk, M. R., Kurmann, T., De Zanet, S., Mosinska, A., Karagoz, I. K., Zinkernagel, M. S., Wolf, S., & Sznitman, R. (2021) · Ophthalmology Retina · doi:10.1016/j.oret.2021.05.002 · Cited by 84
Wang, M., Gu, H., Qian, H., Zhu, W., Zhao, C., Zhang, X., Tao, Y., Zhang, L., & Xu, W. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.017 · Cited by 80
The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema
Singh, R. P., Habbu, K., Ehlers, J. P., Lansang, M. C., Hill, L., & Stoilov, I. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.038 · Cited by 76
Towards the application of precision medicine in Age-Related Macular Degeneration
Cascella, R., Strafella, C., Caputo, V., Errichiello, V., Zampatti, S., Milano, F., Potenza, S., Mauriello, S., Novelli, G., Ricci, F., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.004 · Cited by 76 · cited 1×
“Therefore, the application of these models is very helpful to predict the optimal treatment for an early application on each patient [23].”
MethodGrassmann, F., Schoenberger, P. G. A., Brandl, C., Schick, T., Hasler, D., Meister, G., Fleckenstein, M., Lindner, M., Helbig, H., Fauser, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107461 · Cited by 70
Pin, A.-L., Houle, F., Guillonneau, M., Paquet, É. R., Simard, M. J., & Huot, J. (2012) · Angiogenesis · doi:10.1007/s10456-012-9283-z · Cited by 69
Nguyen, C. L., Oh, L. J., Wong, E. H., Wei, J., & Chilov, M. N. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-0785-3 · Cited by 63
AURA-Studiengruppe, Ziemssen, F., Eter, N., Fauser, S., Bopp, S., Radermacher, M., Hasanbasic, Z., & Holz, F. G. (2015) · Der Ophthalmologe · doi:10.1007/s00347-014-3217-7 · Cited by 62
Anand, A., Sharma, N. K., Gupta, A., Prabhakar, S. K., Sharma, S., Singh, R., & Gupta, P. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049905 · Cited by 62
Romero‐Vázquez, S., Llorens, V., Soler-Boronat, A., Figueras‐Roca, M., Adán, A., & Molins, B. (2021) · Biomedicines · doi:10.3390/biomedicines9070763 · Cited by 62
Gadd, V. L., Patel, P. J., Jose, S., Horsfall, L. U., Powell, E. E., & Irvine, K. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157771 · Cited by 60
The role of lymphocytes and phagocytes in age-related macular degeneration (AMD)
Behnke, V., Wolf, A., & Langmann, T. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03419-4 · Cited by 58
Yamaguchi, M., Fujimori-Tonou, N., Yoshimura, Y., Kishi, T., Okamoto, H., & Masai, I. (2008) · Development · doi:10.1242/dev.011015 · Cited by 56
Expression of VEGFA‐regulating miRNAs and mortality in wet AMD
Błasiak, J., Watała, C. W., Tuuminen, R., Kivinen, N., Koskela, A. K. J., Uusitalo‐Järvinen, H., Tuulonen, A., Winiarczyk, M., Mackiewicz, J., Zmorzyński, S., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14731 · Cited by 51
Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration
Zhang, X., & Lai, T. Y. Y. (2018) · BioMed Research International · doi:10.1155/2018/9640131 · Cited by 50
Litwińska, Z., Sobuś, A., Łuczkowska, K., Grabowicz, A., Mozolewska-Piotrowska, K., Safranow, K., Kawa, M. P., Machaliński, B., & Machalińska, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00286 · Cited by 48
Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration
Grunin, M., Hagbi-Levi, S., Rinsky, B., Smith, Y., & Chowers, I. (2016) · Scientific Reports · doi:10.1038/srep29046 · Cited by 46
Relevance of Complement Factor H–Related 1 (CFHR1) Genotypes in Age-Related Macular Degeneration
Martínez-Barricarte, R., Recalde, S., Fernández-Robredo, P., Millán, I., Olavarrieta, L., Viñuela, A., Pérez-Pérez, J., García-Layana, A., & Rodríguez de Córdoba, S. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8709 · Cited by 43
Yang, Y., & Mei, Q. (2015) · PubMed Central · Cited by 43
Zhao, L., Grob, S., Avery, R., Kimura, A., Pieramici, D., Lee, J., Rabena, M., Ortiz, S., Quach, J., Cao, G., et al. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990048 · Cited by 39
Cascella, R., Strafella, C., Longo, G., Ragazzo, M., Manzo, L., Felici, C. D., Errichiello, V., Caputo, V., Viola, F., Eandi, C. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23241 · Cited by 39
Chang, W., Noh, D. H., Sagong, M., & Kim, I. T. (2013) · PubMed Central · Cited by 38
Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration
Lorés‐Motta, L., de Jong, E. K., & den Hollander, A. I. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0332-1 · Cited by 35
Piermarocchi, S., Miotto, S., Colavito, D., Leon, A., & Segato, T. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12587 · Cited by 34
Huang, C., Xu, Y., Li, X., & Wang, W. (2013) · PubMed Central · Cited by 34
Lederman, M., Weiss, A. T., & Chowers, I. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3019 · Cited by 33
Wang, V. M., Rosen, R. B., MEYERLE, C. B., Kurup, S. K., Ardeljan, D., Agrón, E., Tai, K. W., Pomykala, M., Chew, E. Y., Chan, C., et al. (2012) · PubMed Central · Cited by 32
Ma, L., Tang, F. Y., Chu, W. K., Young, A. L., Brelen, M. E., Pang, C. P., & Chen, L. J. (2016) · Scientific Reports · doi:10.1038/srep19718 · Cited by 30
Larráyoz, I. M., de Luis, A., Rúa, Ó., Velilla, S., Cabello, J., & Martı́nez, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039359 · Cited by 28
Self-citationAmoaku, W. M. K., Balaskas, K., Cudrnak, T., Downey, L., Groppe, M., Mahmood, S., Mehta, H., Mohamed, Q. A., Mushtaq, B., Severn, P. S., et al. (2018) · Clinical ophthalmology · doi:10.2147/opth.s174560 · Cited by 28
Peripheral Monocyte Count and Age-Related Macular Degeneration. The Tongren Health Care Study
Xue, C. C., Cui, J., Gao, L. Q., Zhang, C., Dou, H. L., Chen, D. N., Wang, Y. X., & Jonas, J. B. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.03.010 · Cited by 26
Role of Chemokines in Shaping Macrophage Activity in AMD
Rutar, M., & Provis, J. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_2 · Cited by 24
Daftarian, N., Zandi, S., piryaiee, G., Zarif, M. N., Pirmardan, E. R., Yamaguchi, M., Nejad, Q. B., Hasanpour, H., Samiei, S., Pfister, I. B., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901902rr · Cited by 23
Ulańczyk, Z., Sobuś, A., Łuczkowska, K., Grabowicz, A., Mozolewska‐Piotrowska, K., Safranow, K., Kawa, M. P., Pałucha, A., Krawczyk, M., Sikora, P., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225750 · Cited by 22
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
Hofmans, M., Lammens, T., Depreter, B., Wu, Y., Erlacher, M., Caye‐Eude, A., Cavé, H., Flotho, C., de Haas, V., Niemeyer, C. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82509-5 · Cited by 19
Mansoor, N., Wahid, F., Azam, M., Shah, K., den Hollander, A. I., Qamar, R., & Ayub, H. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190828150625 · Cited by 18
Identification of key miRNAs and genes for mouse retinal development using a linear model
Wang, Y., Wang, X., Jiang, Y., Liu, R., Cao, D., Pan, J., & Luo, Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11082 · Cited by 18
VEGF-mediated angiogenesis in retinopathy of prematurity is co-regulated by miR-17-5p and miR-20a-5p
Guo, Y., Du, F., Tan, Y., Luo, J. F., Xiong, D., & Song, W. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0357 · Cited by 18
ZNF382: A transcription inhibitor down-regulated in multiple tumors due to promoter methylation
Chen, S., Xiao, Z. Y., Zhou, J., Yang, M., Feng, S., Huang, Q., Zou, J., Zeng, T., Li, Y., Peng, L., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.10.021 · Cited by 17
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
Greenberg, E., Hajdu, S. D., Nemlich, Y., Cohen, R. C., Itzhaki, O., Jacob‐Hirsch, J., Besser, M. J., Schachter, J., & Markel, G. (2014) · Open Biology · doi:10.1098/rsob.140030 · Cited by 16
Sharma, S., Baweja, S., Maras, J. S., Shasthry, S. M., Moreau, R., & Sarin, S. K. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100283 · Cited by 16
Pariente, A., Pérez-Sala, Á., Ochoa, R., Peláez, R., & Larráyoz, I. M. (2020) · Cells · doi:10.3390/cells9051187 · Cited by 15
Self-citationRúa, Ó., Larráyoz, I. M., Barajas, M. T., Velilla, S., & Martı́nez, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052696 · Cited by 14
Self-citationAkiyama, M., Takahashi, A., Momozawa, Y., Arakawa, S., Miya, F., Tsunoda, T., Ashikawa, K., Oshima, Y., Yasuda, M., Yoshida, S., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0493-0 · Cited by 14
CX3CR1 polymorphisms and the risk of age-related macular degeneration.
Ma, B., Dang, G., Yang, S., Duan, L., & Zhang, Y. (2015) · PubMed · Cited by 11
Transcriptomic Profiling Explains Racial Disparities in Pterygium Patients Treated With Doxycycline
Larráyoz, I. M., Rúa, Ó., Velilla, S., & Martı́nez, A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14951 · Cited by 10
Self-citationTargeted Gene Candidates for Treatment and Early Diagnosis of Age‐Related Macular Degeneration
Çinici, E., Çağlar, Ö., Arslan, M. E., Dilekmen, N., Utlu, B., Mardinoğlu, A., & Türkez, H. (2021) · BioMed Research International · doi:10.1155/2021/6620900 · Cited by 10
Diack, C., Schwab, D., Cosson, V. F., Buchheit, V., Mazer, N. A., & Frey, N. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.6.11 · Cited by 10
Bonyadi, M. H. J., Yaseri, M., & Soheilian, M. (2020) · Ophthalmic Genetics · doi:10.1080/13816810.2020.1765396 · Cited by 7
Ying, G., & Maguire, M. G. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.0502 · Cited by 1
Dilley, J., & Taylor, S. R. J. (2016) · Investigative Ophthalmology & Visual Science · Cited by 1
Cited by
Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential
Stradiotto, E., Allegrini, D., Fossati, G., Raimondi, R., Sorrentino, T., Tripepi, D., Barone, G., Inforzato, A., & Romano, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113280 · Cited by 29
Biomarkers as Predictive Factors of Anti-VEGF Response
Bobadilla, M., Pariente, A., Ana, I., Peláez, R., Pérez-Sala, Á., & Larráyoz, I. M. (2022) · Biomedicines · doi:10.3390/biomedicines10051003 · Cited by 33
Self-citationCharacteristic Hallmarks of Aging and the Impact on Carcinogenesis
Fiore, M., Terracina, S. A., Ferraguti, G., Petrella, C., Bruno, S. M., Blaconà, G., Certo, M. G. D., Minni, A., Greco, A., Musacchio, A., et al. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220816120353 · Cited by 23
Kozhevnikova, O. S., Фурсова, А. Ж., Derbeneva, A. S., Nikulich, I. F., Сергеевич, Т. М., Devyatkin, V. A., Rumyantseva, Y. V., Telegina, D. V., & Kolosova, N. G. (2022) · Biomedicines · doi:10.3390/biomedicines10071658 · Cited by 17
Lalman, C., Yang, Y., & Walker, J. L. (2025) · Cells · doi:10.3390/cells14171315 · Cited by 29
Metadata
- Authors
- Oca, A. I., Pérez-Sala, Á., Pariente, A., Ochoa, R., Velilla, S., Peláez, R., & Larráyoz, I. M.
- Affiliations
- Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, 26006 Logroño, La Rioja, Spain
- Center for Biomedical Research of La Rioja (ES)
- Universidad de La Rioja (ES)
- Corresponding author
- Larráyoz, Ignacio M.
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2021-12-08
- Volume
- 11
- Issue
- 12
- Pages
- 1329
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC8706948
- OpenAlex
- W4200024873
- Cited by
- 25
- References
- 82
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 2 · 2023: 6 · 2022: 6
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RIUR (Universidad de La Rioja) (submittedVersion, other-oa)
- Funders
- Instituto de Salud Carlos III (PI19/01805, CPII20/00029)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- age-related macular degeneration, anti-VEGF therapy, ranibizumab, predictive biomarkers, treatment response prediction, peripheral blood mononuclear cells, transcriptome, mRNA biomarkers, microRNA biomarkers, choroidal neovascularization, personalized medicine, inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.